A phase 2 trial of mini‐hyper‐<scp>CVD</scp>, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia

Authors: Wei‐Ying Jen, Elias Jabbour, Nicholas J. Short, Ghayas C. Issa, Fadi G. Haddad, Nitin Jain, Naveen Pemmaraju, Naval G. Daver, Lucia Masarova, Gautam Borthakur, Kelly Chien, Rebecca Garris, Hagop M. Kantarjian

Published: 2024-08-28

DOI: HTTPS://DOI.ORG/10.1002/ajh.27463

Keywords: No keywords found.

Abstract:
No abstract found.

Source: